Publications

Welcome to our Publications Directory. As Australia's peak allergy research body, here you will find the latest evidence out of the drug, food, insect and respiratory allergy studies involving our leading experts.

• For more information about studies currently recruiting and underway across Australia, visit the NACE Allergy Studies Directory.
• For advice on how to acknowledge your NACE affiliation if you are involved in research supported, conducted and/or funded by the NACE, see our Publications Guidelines. 

• 
  Respiratory allergy Jan 2025

  Aerobiology matters: Why people in the community access pollen information and how they use it

  Clinical and Translational Allergy

  Read more

• 
  Respiratory allergy Nov 2024

  A global survey addressing sustainability of pollen monitoring

  World Allergy Organization Journal

  Read more

• 
  Respiratory allergy Jul 2024

  Forecasting daily total pollen concentrations on a global scale

  Allergy.

  Read more

• 
  Respiratory allergy May 2024

  Seasonal Patterns and Allergenicity of Casuarina Pollen in Sydney, Australia: Insights from 10 Years of Monitoring and Skin Testing

  Atmosphere

  Read more

• 
  Respiratory allergy Apr 2024

  Environmental DNA analysis of airborne poaceae (grass) pollen reveals taxonomic diversity across seasons and climate zones

  Environmental Research.

  Read more

• 
  Respiratory allergy Apr 2024

  Nanofluidic point-of-care IgE test for subtropical grass pollen for rapid diagnosis of allergic rhinitis

  Annals of Allergy, Asthma & Immunology.

  Read more

• 
  Respiratory allergy Jan 2024

  Informing spatial distributions and temporal variations of grass pollen sources in urban landscapes using 10 m Sentinel-2 data

  Read more

• 
  Respiratory allergy Nov 2023

  Airborne grass pollen and thunderstorms influence emergency department asthma presentations in a subtropical climate

  Environmental Research.

  Read more

• 
  Respiratory allergy Sep 2023

  Digital inhaler preferences of asthma patients and healthcare providers: a discrete choice experiment

  ERS Publications.

• 
  Respiratory allergy Aug 2023

  Biologics (mepolizumab and omalizumab) induced remission in severe asthma patients

  Allergy.

  Read more

If you would like to request a PDF version of a full article, please email [email protected]